| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 718564 | Null | 0.0112651116880208 | 0.10264519 |
| NSC 718781 | Erlotinib hydrochloride | 0.0112651116880208 | -0.24471524 |
| NSC 725098 | Null | 0.0112651116880208 | 0.44669154 |
| NSC 731704 | 1-[4-Ethoxycarbonyl)homopiperazine-1-yl]diazen-1-ium-1,2-dio late. | 0.0112651116880208 | 0.32614364 |
| NSC 750050 | Null | 0.011265111688021 | 0.64708158 |
| NSC 753456 | 2-4-[5-(3,5-dimethoxyphenyl)-1H-1-imidazolyl]phenyl-5,6,7-trimethoxy-1,3-benzothiazole | 0.011265111688021 | 0.57144598 |
| NSC 762908 | 2-(4-(methylsulfonyl)phenyl)-6-p-tolyl-4,5-dihydropyridazin-3(2H)-one | 0.011265111688021 | 0.65946697 |
| NSC 750332 | 4-(4-chlorophenyl)-1-3-[(E)-3-(3,4,5-trimethoxyphenyl)-2-propenoyl]phenyl-2,3-dihydro-1H-2-imidazolone | 0.011544784012433 | 0.26446266 |
| NSC 761039 | Null | 0.011544784012433 | 0.67333897 |
| NSC 140380 | Ethanesulfonic acid, compd. with 4-[[2-chloro-4-(4,6-diamino-2,2-dimethyl-1,3,5-triazin-1(2H)-yl)phenoxy]acetyl]morpholine (1:1) (9CI) (MF2) | 0.0115447840124334 | 0.42586565 |